| Model: | Ratio |
| Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 4589 | 40.6 | 4927561 | |
| ZYME | Zymeworks Inc. Common Stock | Healthcare | Biotechnology | 1484 | 19.68 | 596824 |
| Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
| Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
| MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
| RSI Period: | 14 | RSI Threshold: | 0 | ||
| Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
| Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 | |
| Initial Capital: | 10000.00 | Final Equity: | -1274.19 |
| Total net P/L: | -11274.19 | Total ROI: | -112.74 % |
| CAGR: | 0.00 % | Max. DD: | 109.65 % |
| System Score: | 0.000 | Sharpe Ratio: | 0.581 |
| Start Date: | 2020-01-02 | End Date: | 2025-02-28 |
| Total days: | 1884 | ||
| Commissions: | 558.20 | Comm.% P/L | 5.21 % |
| Total Transactions: | 180 | Log. Linearity: | 77.919 % |
| Total | Long |
Short |
VKTX | ZYME | |
|---|---|---|---|---|---|
| Total Profit/Loss | -10715.99 | 221.77 | -10937.76 | -10238.66 | -477.33 |
| Total Profit | 10518.41 | 5056.29 | 5462.12 | 7708.14 | 11305.57 |
| Total Loss | 21234.40 | 4834.52 | 16399.88 | 17946.80 | 11782.90 |
| Profit Factor | 0.50 | 1.05 | 0.33 | 0.43 | 0.96 |
| Trades | 45 | 17 | 28 | 45 | 45 |
| Winning Trades | 32 | 13 | 19 | 20 | 31 |
| Losing Trades | 13 | 4 | 9 | 24 | 14 |
| % Profitable | 71.00 | 76.00 | 67.00 | 44.00 | 68.00 |
| Profit/Loss Per Trade % | 0.00 | 1.04 | 0.00 | 0.00 | 0.26 |
| Profit Per Trade % | 7.59 | 8.41 | 7.03 | 7.89 | 8.92 |
| Loss Per Trade % | 26.41 | 17.07 | 30.79 | 12.71 | 14.98 |
| Days In Trade | 507 | 168 | 339 | 507 | 507 |
| Days In Trade (Avg. Per Trade) | 11.27 | 9.88 | 12.11 | 11.27 | 11.27 |
| % Days In Trade | 26.91 | 8.92 | 17.99 | 26.91 | 26.91 |